The subtypes with the highest to lowest mutation frequencies were HER‐2‐positive breast cancer (114/155, 73.5%), triple‐negative breast cancer (TNBC, 183/267, 68.5%) and luminal‐subtype breast cancer (301/696, 43.2%) (p < 0.001). Here, ERBB2 is linked to breast carcinoma.